Patents Assigned to DCV, Inc.
-
Publication number: 20030143190Abstract: Disclosed is an isolated Cytokine Activating Factor (CAF) protein, an isolated nucleic acid molecule encoding a CAF protein, an antibody that selectively binds to a CAF protein, a composition comprising a Cytokine Activating Factor (CAF), and a method for modulating the immune system using the composition. Also disclosed is a method for treating cancer using such a composition.Type: ApplicationFiled: May 14, 2002Publication date: July 31, 2003Applicant: DCV, Inc.Inventors: Subramanian Iyer, Tay N. Nguyen, Dauh-Rurng Wu, Ruye Xing
-
Publication number: 20030125573Abstract: The invention provides a method of producing &agr;-tocopherol and &agr;-tocopheryl esters. The method comprises using a biological system to produce farnesol or geranylgeraniol. Then, the farnesol or geranylgernaiol is chemically converted into &agr;-tocopherol or an &agr;-tocopheryl ester.Type: ApplicationFiled: July 9, 2001Publication date: July 3, 2003Applicant: DCV, Inc., d/b/a Bio-Technical ResourcesInventors: James R. Millis, Gabriel G. Saucy, Julie Maurina-Brunker, Thomas W. McMullin
-
Publication number: 20030092144Abstract: The invention provides a biological method of producing farnesol or geranylgeraniol.Type: ApplicationFiled: July 20, 2001Publication date: May 15, 2003Applicant: DCV, Inc. d/b/a Bio-Technical Resources.Inventors: James R. Millis, Julie Maurina-Brunker, Thomas W. McMullin
-
Patent number: 6410755Abstract: The invention provides a method of producing &agr;-tocopherol and &agr;-tocopheryl esters. The method comprises using a biological system to produce farnesol or geranylgeraniol. Then, the farnesol or geranylgernaiol is chemically converted into &agr;-tocopherol or an &agr;-tocopheryl ester.Type: GrantFiled: July 6, 1999Date of Patent: June 25, 2002Assignee: DCV, Inc.Inventors: James R. Millis, Gabriel G. Saucy, Julie Maurina-Brunker, Thomas W. McMullin
-
Patent number: 6242227Abstract: The invention provides a method of producing &agr;-tocopherol and &agr;-tocopheryl esters. The method comprises using a biological system to produce farnesol or geranylgeraniol. Then, the farnesol or geranylgernaiol is chemically converted into &agr;-tocopherol or an &agr;-tocopheryl ester.Type: GrantFiled: July 6, 1999Date of Patent: June 5, 2001Assignees: DCV, Inc., Eastman Chemical CompanyInventors: James R. Millis, Gabriel G. Saucy, Julie Maurina-Brunker, Thomas W. McMullin, John A. Hyatt
-
Patent number: 6225100Abstract: The present invention relates to novel arylsulfotransferases. In particular, the present invention relates to novel arylsulfotransferas from Clostridium and from Eubacterium innocuum.Type: GrantFiled: January 8, 1999Date of Patent: May 1, 2001Assignee: DCV, Inc.Inventors: Julie Maurina-Brunker, Alan D. Grund
-
Patent number: 6217865Abstract: The invention relates to blending eggs from all egg lots produced over a predetermined time period of the egg laying cycle of immunized avians, to form an antibody-containing substance. The administration of an effective amount of such a blended antibody-containing substance to a subject increases the efficacy of the antibody in the subject over that of administering a substance containing the same amount of antibody obtained from eggs collected over less than the predetermined period of time.Type: GrantFiled: April 8, 1998Date of Patent: April 17, 2001Assignee: DCV, Inc.Inventor: Jeffrey G. Hunchar
-
Patent number: 6167652Abstract: Application of a water-soluble salt of chitosan to the foliage of growing plants increases the yield of vegetables, tubers, cereal grains, fruits and blossoms. Plants so treated are healthier, sturdier, more resistant to drought and many varieties enjoy an extended period of production. The plants may be effectively and conveniently treated by spraying the foliage with a solution containing 0.01-1.5% wt. chitosan salt using conventional agricultural equipment and techniques.Type: GrantFiled: January 26, 1999Date of Patent: January 2, 2001Assignee: DCV, Inc.Inventors: George E. Heinsohn, August S. Bjornson
-
Patent number: 6136985Abstract: The present invention provides CLA esters and uses thereof. More particularly, the present invention provides a composition for topical use comprising CLA esters and a topical carrier. In addition, the present invention specifically provides tocopheryl CLA esters, ascorbyl CLA esters and retinyl CLA esters.Type: GrantFiled: December 21, 1998Date of Patent: October 24, 2000Assignee: DCV, Inc.Inventor: James R. Millis
-
Patent number: 6086878Abstract: The invention is directed to a method and food product for achieving at least one of the following: increasing muscle protein or reducing fat in an animal. The method comprises administering to the animal an effective amount of a composition comprising a gastrointestinal neuro-modulator antibody in order to neutralize the gastrointestinal neuro-modulator.Type: GrantFiled: August 21, 1997Date of Patent: July 11, 2000Assignee: DCV, Inc.Inventors: Orn Adalsteinsson, Sandra G. Fitzpatrick-McElligott, Jeffrey G. Hunchar
-
Patent number: 5945159Abstract: The invention is directed to a method for the encapsulation of very finely divided solids within a continuous impervious coating of thermoplastic material. The method is carried out with continuous agitation during which the particles are coated with a plurality of sprayed layers of thermoplastic coating material while maintaining the particles in free-flowing powder consistency during the coating steps.Type: GrantFiled: December 12, 1996Date of Patent: August 31, 1999Assignee: DCV, Inc.Inventor: Joseph L. Sell
-
Patent number: 5932250Abstract: The present invention is directed to the treatment of vascular disorders particularly arteriosclerosis and atherosclerosis in warm-blooded animals. The invention encompasses the ingestion, by warm-blooded animals, of eggs or egg fractions derived from female avians that have been hyperimmunized with specific bacterial antigens or groups of bacterial antigens. The invention is directed to methods of controlling cholesterol levels, lipid deposits, and the development of atheromatous lesions in warm-blooded animals by the ingestion of eggs or fractions thereof produced in female avians hyperimmunized with specific bacterial antigens. The invention is also directed to methods of producing the eggs and to vaccines for hyperimmunization of the female avians.Type: GrantFiled: June 7, 1995Date of Patent: August 3, 1999Assignee: DCV, Inc.Inventors: Ralph J. Stolle, Lee R. Beck
-
Patent number: 5922774Abstract: Method for repelling insect herbivores from plant surfaces and deterring them from feeding on plant surfaces by applying an aqueous dispersion of polycyclic quinone or precursor thereof to the foliage of the plant and/or to the surrounding soil in which the plant is rooted.Type: GrantFiled: October 22, 1996Date of Patent: July 13, 1999Assignee: DCV, Inc.Inventor: Anna Louise Winslow
-
Patent number: 5922110Abstract: A water-soluble, biodegradable filter medium for removing entrained solid and/or liquid particles from an air stream, and a method of use thereof are disclosed. The filter medium is a solid solution of starch and a biodegradable, water-soluble synthetic polymer. After use, the filter medium is disposed of in an environmentally sound fashion. In particular, the filter medium is dissolved in water and the solid and/or liquid particles collected thereon are removed from the resulting aqueous solution of starch and polymer by decantation and the polymer and starch biodegraded using a conventional biological water treatment process.Type: GrantFiled: January 21, 1998Date of Patent: July 13, 1999Assignee: DCV, Inc.Inventors: Harvey L. Weaver, Donald Mark Cyron
-
Patent number: 5910622Abstract: Method for treating fibrous cellulosic materials using an aqueous cationic treating solution containing a cyclic polyhydroxy compound and choline chloride, by which dye uptake of the material, and the environmental effects of the subsequent dyeing process are improved.Type: GrantFiled: June 2, 1997Date of Patent: June 8, 1999Assignee: DCV, Inc.Inventor: George L. Brodmann
-
Patent number: 5853765Abstract: The present invention is directed to the treatment of vascular disorders particularly arteriosclerosis and atherosclerosis in warm-blooded animals. The invention encompasses the ingestion, by warm-blooded animals, of eggs or egg fractions derived from female avians that have been hyperimmunized with specific bacterial antigens or groups of bacterial antigens. The invention is directed to methods of controlling cholesterol levels, lipid deposits, and the development of atheromatous lesions in warm-blooded animals by the ingestion of eggs or fractions thereof produced in female avians hyperimmunized with specific bacterial antigens. The invention is also directed to methods of producing the eggs and to vaccines for hyperimmunization of the female avians.Type: GrantFiled: June 7, 1995Date of Patent: December 29, 1998Assignee: DCV, Inc.Inventors: Ralph J. Stolle, Lee R. Beck
-
Patent number: 5849349Abstract: Eggs that affect lipid and cholesterol levels obtained from avian species that are hyperimmunized against a variety of bacterial antigens are disclosed. These eggs are useful as a dietary supplement for humans and other animals.Type: GrantFiled: June 7, 1995Date of Patent: December 15, 1998Assignee: DCV, Inc.Inventors: Ralph J. Stolle, Lee R. Beck
-
Patent number: 5792631Abstract: The present invention is directed to methods for the production of ascorbic acid by culturing organisms of the species C. protothecoides and recovering ascorbic acid from the fermentation medium.Type: GrantFiled: June 7, 1995Date of Patent: August 11, 1998Assignee: DCV, Inc.Inventor: Jeffrey Running